Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models
Xiaohui Si, Lu Xiao, Christine E. Brown, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3154-3154
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Oral Cancer Stem Cells: A Comprehensive Review of Key Drivers of Treatment Resistance and Tumor Recurrence
P J Nagarathna, Santosh Patil, Vishnu Priya Veeraraghavan, et al.
European Journal of Pharmacology (2025), pp. 177222-177222
Closed Access | Times Cited: 2
GD2-targeting therapy: a comparative analysis of approaches and promising directions
Julia Philippova, Julia Shevchenko, С. В. Сенников
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Progress in developing microphysiological systems for biological product assessment
Mona Mansouri, Johnny Lam, Kyung E. Sung
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1293-1306
Open Access | Times Cited: 11
Efficient combination of radiotherapy and CAR-T – A systematic review
Wojciech Szlasa, Aleksandra Sztuder, Agnieszka Kaczmar-Dybko, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116532-116532
Open Access | Times Cited: 8
Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches
Tianning Gu, Meng Zhu, He Huang, et al.
Journal of Zhejiang University SCIENCE B (2022) Vol. 23, Iss. 10, pp. 793-811
Open Access | Times Cited: 24
CAR T-cells to treat brain tumors
Grace Guzman, Karolina Pellot, Megan R. Reed, et al.
Brain Research Bulletin (2023) Vol. 196, pp. 76-98
Open Access | Times Cited: 13
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Alfredo Sebastian Colina, Viren Shah, Ravi K. Shah, et al.
Frontiers in Molecular Medicine (2024) Vol. 4
Open Access | Times Cited: 4
Non-viral vectors for chimeric antigen receptor immunotherapy
Sandy Tretbar, Joel G. Rurik, Even H Rustad, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 4
New approach methodologies to assess wanted and unwanted drugs-induced immunostimulation
Valeria Bettinsoli, Gloria Melzi, I. Marchese, et al.
Current Research in Toxicology (2025) Vol. 8, pp. 100222-100222
Open Access
Precise CAR-T-cell Therapy Targeting Non-Cancerous Diseases: Advances in Precision Medicine and Bioengineering
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1035-1035
Open Access | Times Cited: 3
Quality Assessment Strategy Development and Analytical Method Selection of GMP Grade Biological Drugs for Gene and Cell Therapy
Quan‐en Yang, Nicole Lee, Nicole L. Johnson, et al.
BBA Advances (2025) Vol. 7, pp. 100151-100151
Open Access
A Quantitative Approach to Potency Testing for Chimeric Antigen Receptor-Encoding Lentiviral Vectors and Autologous CAR-T Cell Products, Using Flow Cytometry
Juan José Mata, Letícia Alserawan, Carolina España, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 303-303
Open Access
Model‐informed drug development of autologous CAR‐T cell therapy: Strategies to optimize CAR‐T cell exposure leveraging cell kinetic/dynamic modeling
Anna M. Mc Laughlin, Peter A. Milligan, Cassian Yee, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 11, pp. 1577-1590
Open Access | Times Cited: 8
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
(2024)
Open Access | Times Cited: 3
A dual-luciferase bioluminescence system for the assessment of cellular therapies
Alejandro G. Torres Chavez, Mary K. McKenna, Kishore Balasubramanian, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200763-200763
Open Access | Times Cited: 2
Syngeneic Mouse Models for Pre-Clinical Evaluation of CAR T Cells
Eman Nayaz Ahmed, Lauren C. Cutmore, John F. Marshall
Cancers (2024) Vol. 16, Iss. 18, pp. 3186-3186
Open Access | Times Cited: 2
Perspective: The Role of Cryopreservation Techniques in Manufacturing, Transport, and Storage of Car-T Therapy Products
Miroslava Jandová, Glyn Nigel Stacey, M. Lánská, et al.
Cryoletters (2023) Vol. 44, Iss. 3, pp. 123-133
Open Access | Times Cited: 6
Precise surface functionalization of PLGA particles for human T cell modulation
Pierce Hadley, Yuanzhou Chen, Lariana Cline, et al.
Nature Protocols (2023) Vol. 18, Iss. 11, pp. 3289-3321
Open Access | Times Cited: 6
DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges
Akihiko Goto, Yuu Moriya, Miyu Nakayama, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 56, pp. 101003-101003
Open Access | Times Cited: 1
Imaging‐Based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids
Seong‐Eun Kim, Suji Yun, Junsang Doh, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 27
Open Access | Times Cited: 1
Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies
Arun Kumar Arunachalam, Céline Gregoire, Beatriz Coutinho de Oliveira, et al.
Blood Reviews (2024), pp. 101241-101241
Open Access | Times Cited: 1
Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies
Stephanie M. Bates, Kelly V. Evans, Louise Delsing, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104239-104239
Closed Access | Times Cited: 1
A Pathologist’s Guide to Non-clinical Safety Assessment of Adoptive Cell Therapy Products
Alessandra Piersigilli, Vinicius Carreira, Frédéric Gervais, et al.
Toxicologic Pathology (2024)
Closed Access | Times Cited: 1
Evolving strategies for addressing CAR T-cell toxicities
Alexander W. Rankin, Brynn B. Duncan, Cecily Allen, et al.
Cancer and Metastasis Reviews (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top